Updated COVID-19 rapid guideline: haematopoietic stem cell transplantation

Changes have been made to a number of recommendations, as well as removal of recommendations 3.3, 3.4 and 7.3 that advised deferring most autologous and allogeneic haematopoietic stem cell transplants, to reflect changes in the risk of infection and the capacity in services.

National Institute for Health and Care Excellence